Human DNA methylation signatures differentiate persistent from resolving MRSA bacteremia
- 9 March 2021
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (10)
- https://doi.org/10.1073/pnas.2000663118
Abstract
Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is life threatening and occurs in up to 30% of MRSA bacteremia cases despite appropriate antimicrobial therapy. Isolates of MRSA that cause antibiotic-persistent methicillin-resistant S. aureus bacteremia (APMB) typically have in vitro antibiotic susceptibilities equivalent to those causing antibiotic-resolving methicillin-resistant S. aureus bacteremia (ARMB). Thus, persistence reflects host–pathogen interactions occurring uniquely in context of antibiotic therapy in vivo. However, host factors and mechanisms involved in APMB remain unclear. We compared DNA methylomes in circulating immune cells from patients experiencing APMB vs. ARMB. Overall, methylation signatures diverged in the distinct patient cohorts. Differentially methylated sites intensified proximate to transcription factor binding sites, primarily in enhancer regions. In APMB patients, significant hypomethylation was observed in binding sites for CCAAT enhancer binding protein-β (C/EBPβ) and signal transducer/activator of transcription 1 (STAT1). In contrast, hypomethylation in ARMB patients localized to glucocorticoid receptor and histone acetyltransferase p300 binding sites. These distinct methylation signatures were enriched in neutrophils and achieved a mean area under the curve of 0.85 when used to predict APMB using a classification model. These findings validated by targeted bisulfite sequencing (TBS-seq) differentiate epigenotypes in patients experiencing APMB vs. ARMB and suggest a risk stratification strategy for antibiotic persistence in patients treated for MRSA bacteremia.Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (UO1-AI124319)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (RO1-AI068804)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R33-AI111661)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (UO1-AI124319)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (U19AI128913)
This publication has 60 references indexed in Scilit:
- BS-Seeker2: a versatile aligning pipeline for bisulfite sequencing dataBMC Genomics, 2013
- BLUEPRINT: mapping human blood cell epigenomesHaematologica, 2013
- GENCODE: The reference human genome annotation for The ENCODE ProjectGenome Research, 2012
- methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profilesGenome Biology, 2012
- DNA Demethylation DynamicsCell, 2011
- STAT1-Activating Cytokines Limit Th17 Responses through Both T-bet–Dependent and –Independent MechanismsThe Journal of Immunology, 2010
- A partial form of recessive STAT1 deficiency in humansJCI Insight, 2009
- Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsisIntensive Care Medicine, 2009
- Phenotypic and Genotypic Characteristics of Persistent Methicillin‐ResistantStaphylococcus aureusBacteremia In Vitro and in an Experimental Endocarditis ModelThe Journal of Infectious Diseases, 2009
- C/EBPβ is required for 'emergency' granulopoiesisNature Immunology, 2006